Study of oxygen levels at night and during exercise in fibrotic lung disease
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at how oxygen levels change at night and during a short walk in people with fibrotic interstitial lung disease (a type of lung scarring). The goal is to understand these changes better, which could help improve care for people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a diagnosis of fibrotic interstitial lung disease with more than 10% scarring (fibrosis) seen on a CT scan of your chest.
- You must be able to give written consent to take part.
- You should not be currently using long-term oxygen therapy, and you should not have severe sleep apnea (interrupted breathing during sleep) that requires treatment.
- Your CT scan should show that the main problem is scarring, not emphysema (another lung disease).
- You should not have other serious health conditions, like uncontrolled high blood pressure, recent heart problems, or pulmonary hypertension, that would make exercise testing unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to track lung scarring (fibrosis) over time in people with conditions like IPF, other fibrotic lung diseases, or early signs of scarring. It might help doctors understand how the disease changes.
This study looks at how well skeletal (muscle) function supports exercise in people with interstitial lung diseases (including idiopathic pulmonary fibrosis). It may help better understand fitness and breathing limits, which can guide rehabilitation choices and future care.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This study is for people with a specific type of lung scarring (not IPF) to understand how the disease progresses. Researchers will collect detailed health information, imaging, and blood samples to learn more about the condition.
This study compares using oxygen continuously versus only when needed for people with fibrotic interstitial lung disease or COPD. It aims to find which method improves daily life and activity.
This study is testing whether using portable oxygen during physical activity can help people with mild-to-moderate interstitial lung disease feel better and be more active. It is for people whose oxygen levels drop during exercise but are normal at rest.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.